David A. Siegel Pulmonx Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pulmonx Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 94,900 shares of LUNG stock, worth $594,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,900
Previous 132,000
28.11%
Holding current value
$594,074
Previous $836,000
5.98%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$35.5 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.3 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.52 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $233M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...